2019
DOI: 10.1007/s10974-019-09513-1
|View full text |Cite
|
Sign up to set email alerts
|

Troponin structure and function: a view of recent progress

Abstract: The molecular mechanism by which Ca 2+ binding and phosphorylation regulate muscle contraction through Troponin is not yet fully understood. Revealing the differences between the relaxed and active structure of cTn, as well as the conformational changes that follow phosphorylation has remained a challenge for structural biologists over the years. Here we review the current understanding of how Ca 2+ , phosphorylation and disease-causing mutations affect the structure and dynamics of troponin to regulate the th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
76
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(77 citation statements)
references
References 79 publications
1
76
0
Order By: Relevance
“…Our simulated twitches suggest that the TI of D230N cardiomyocytes can be greatly increased by augmenting Ca 2+ binding to cTnC ( Figure 2B ). When Ca 2+ binds to cTnC, allosteric interactions in the Tn complex cause the inhibitory peptide region of cTnI to reduce its interaction with actin ( 23 25 ), which enables Tm to move from a blocked state to closed and open states that permit varying degrees of XB binding ( 22 ). The activated state of the Tn-Tm complex is stabilized by interactions between the switch peptide of cTnI and cTnC (see ref.…”
Section: Resultsmentioning
confidence: 99%
“…Our simulated twitches suggest that the TI of D230N cardiomyocytes can be greatly increased by augmenting Ca 2+ binding to cTnC ( Figure 2B ). When Ca 2+ binds to cTnC, allosteric interactions in the Tn complex cause the inhibitory peptide region of cTnI to reduce its interaction with actin ( 23 25 ), which enables Tm to move from a blocked state to closed and open states that permit varying degrees of XB binding ( 22 ). The activated state of the Tn-Tm complex is stabilized by interactions between the switch peptide of cTnI and cTnC (see ref.…”
Section: Resultsmentioning
confidence: 99%
“…HCM and DCM mutations can occur in the same protein like in human cardiac troponin T (hcTnT) (Kamisago et al, 2000;Marston and Hodgkinson, 2001;Song et al, 2005;Lu et al, 2013). Cardiac troponin T (cTnT) transfers the Ca 2+ binding event from cardiac troponin C (cTnC) to troponin I (cTnI) and tropomyosin (Tm) [recently reviewed in (Marston and Zamora, 2020)]. Previous studies investigating individual mutations in these regulatory proteins associated with HCM and DCM either mostly reported negative or no consequence of mutations on LDA (Li et al, 2013;Sequeira et al, 2013;Mickelson and Chandra, 2017;Chandra, 2018, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…We highlight the upstream effect that TNNI3 may be having on heart muscle contraction, which may be having a negative downstream effect on a wide range of biological processes in the nervous, respiratory and digestive systems (see Supplementary Figure 1 for a bubble plot of genetically associated processes with TNNI3). In addition, we identify levosimendan, a positive inotropic agent having ATP-dependent potassium-channel-opening and calcium-sensitizing effects by binding to a calcium sensing myocardial complex consisting of cardiac troponin C and troponin I(20) ,(21,22) . This is a clinically approved drug used for heart failure, kidney failure and SARS (https://www.targetvalidation.org/summary?drug=CHEMBL2051955).…”
Section: Resultsmentioning
confidence: 99%